Acute complications of insulin pump therapy

Diabetes Research and Clinical Practice

Volumn 74, Issue SUPPL. 2, 2006, Pages

  Guerci, Bruno ^a  

^a Ctr Hospitalier Univ de Nancy   (France)

Author keywords

Continuous subcutaneous insulin infusion; Diabetic ketoacidosis; Hypoglycemia; Insulin analogues; Insulin pump

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; KETONE;

ARTICLE; BOLUS INJECTION; CLINICAL PRACTICE; DEVICE; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; METABOLIC DISORDER;

EID: 33845585288     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(06)70009-2     Document Type: Article

References (10)

1. Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care 18 (1995) 1415-1427
2. Binder C., Lauritzen T., Faber O., and Pramming S. Insulin pharmacokinetics. Diabetes Care 7 (1984) 188-199
3. Egger M., Davey Smith G., Stettler C., and Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 14 (1997) 919-928
4. Brange J., Owens D.R., Kang S., and Volund A. Monomeric insulins and their experimental and clinical implications. Diabetes Care 13 (1990) 923-954
5. Guerci B., Meyer L., Salle A., Charrie A., Dousset B., Ziegler O., et al. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab 84 (1999) 2673-2678
6. Melki V., Renard E., Lassmann-Vague V., Boivin S., Guerci B., Hanaire-Broutin H., et al., Augendre-Ferrante B., Tauber J.P. Improvement of HbAlc and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21 (1998) 977-982
7. Bode B.W., Steed R.D., and Davidson P.C. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 19 (1996) 324-327
8. Retnakaran R., Hochman J., DeVries J.H., Hanaire-Broutin H., Heine R.J., Melki V., et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline Alc. Diabetes Care 27 (2004) 2590-2596
9. Lepore M., Pampanelli S., Fanelli C., Porcellati F., Bartocci L., Di Vincenzo A., et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49 (2000) 2142-2148
10. Doyle E.A., Weinzimer S.A., Steffen A.T., Ahern J.A., Vincent M., and Tamborlane W.A. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27 (2004) 1554-1558